But Biden aides privately told The Associated Press that they expect Trump to continue the planned projects and take credit ...
After the double-blind Part 1, eligible patients may continue to the open-label Part 2 for up to 24 weeks of dosing ... The only exceptions are the United States and Canada, where the business sectors ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback